National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
Tang
W H Wilson
WH
Francis
Gary S
GS
Morrow
David A
DA
Newby
L Kristin
LK
Cannon
Christopher P
CP
Jesse
Robert L
RL
Storrow
Alan B
AB
Christenson
Robert H
RH
Apple
Fred S
FS
Ravkilde
Jan
J
Wu
Alan H B
AH
D015415:Biomarkers / Q000097:blood; D015897:Comorbidity; D003955:Diagnostic Tests, Routine / Q000191:economics / Q000706:statistics & numerical data; D004347:Drug Interactions; D004417:Dyspnea / Q000209:etiology; D019317:Evidence-Based Medicine; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D006333:Heart Failure / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000191:economics; D006801:Humans; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011237:Predictive Value of Tests; D012372:ROC Curve; D012016:Reference Values; D015203:Reproducibility of Results; D018570:Risk Assessment; D020107:Troponin T / Q000097:blood
D015415:Biomarkers; D010446:Peptide Fragments; D020107:Troponin T; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain